Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies.
Clin Pharmacokinet
; 55(9): 1091-101, 2016 09.
Article
in En
| MEDLINE
| ID: mdl-27000758
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Protease Inhibitors
/
Hepatitis C
/
Ritonavir
/
Macrocyclic Compounds
/
Drug Compounding
Type of study:
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Pharmacokinet
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland